Hiroyuki Yamada, MD | Authors

UFT Plus Leucovorin for Metastatic Colorectal Cancer: Japanese Experience

October 01, 2000

In the United States and Europe, the combination of oral UFT plus leucovorin has been reported to produce objective responses and survival rates similar to those achieved with standard intravenous 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer, with reduced toxicity.